They could be boosted though by the acquisition in May of the Greek pharmaceutical company Specifar for 400m euros by Watson Pharmaceuticals of California, which has its headquarters in New Jersey.
Te cifre će možda biti ohrabrujuće zbog akvizicije grčke farmaceutske kompanije Specifar u maju mesecu za 400 miliona evra od strane kalifornijske kompanije Votson Farmasutikals, sa centralom u Nju Džersiju.